Projects per year
Personal profile
Further information
Branches of science
- 305 Other Human Medicine, Health Sciences
Fingerprint
Dive into the research topics where Peter Michael Rohrer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Psychological and physiological stress and stress reactivity in patients with recently diagnosed Uveal Melanoma
Egger, J. W. (Principal investigator), Wackernagel, W. (Co-investigator), Rohrer, P. M. (Co-investigator), Trapp, M. (Co-investigator), Langmann, G. (Co-investigator), Trapp, E.-M. (Co-investigator) & Mayer-Xanthaki, C. (Co-investigator)
1/04/12 → 31/12/13
Project: Research funding
-
Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project
Gebhardt, C., Debus, D., Rohrer, P. M., Kähler, K., Koch, L., Terheyden, P. & Nguyen, V., 31 Dec 2025, In: Melanoma Management. 12, 1, p. 2545167 17 p., 2545167.Research output: Contribution to journal › Review
1 Citation (Web of Science) -
Coping and vegetative reactivity in uveal melanoma
Gabriel, M. (First author), Trapp, E.-M., Rohrer, P. M., Trapp, M., Schwantzer, G., Mester, A., Richtig, E., Schwab, C., Langmann, G., Egger, J. W. & Mayer-Xanthaki, C. F. (Last author), Dec 2024, In: Spektrum der Augenheilkunde. 38, 6, 7 p.Research output: Contribution to journal › Research article
-
Retrospective individual case reports on the treatment of patients with advanced BRAFV600-mutant malignant melanoma with encorafenib plus binimetinib (REMINISCENCE): focus on patients with brain metastases
Debus, D., Rohrer, P. M., Grote, C., Kähler, K., Koch, L., Reichenbach, F., Terheyden, P. & Nguyen, V., Sept 2023, In: JDDG - Journal of the German Society of Dermatology. 21, p. 79-80 2 p.Research output: Contribution to journal › Conference abstract
-
Retrospective Single Case Reports on the Treatment of Advanced BRAFV600-mutated Malignant Melanoma with Encorafenib plus Binimetinib (REMINISCENCE)
Debus, D., Alter, M., Dernoscheg, M.-T., Rohrer, P. M., Koch, L., Nguyen, V. & Terheyden, P., 2022, In: Oncology Research and Treatment.Research output: Contribution to journal › Conference abstract
-
Retrospective Survey of Individual Case Reports on Treatment Situations in Patients with locally advanced or metastatic, BRAFV600-mutated Melanoma with Encorafenib and Binimetinib (REMINISCENCE).
Grote, C., Debus, D., Bluhm, L., Koch, L., Alter, M., Dernoscheg, M.-T., Nepel, C. R., Rohrer, P. M., Kahler, K., Tuting, T., Gengen-Bacher, L., Nguyen, V. & Terheyden, P., 2022, In: JDDG - Journal of the German Society of Dermatology.Research output: Contribution to journal › Conference abstract
1 Citation (Web of Science)
-
Retrospective individual case reports on the treatment of patients with advanced BRAFV600-mutant malignant melanoma with encorafenib plus binimetinib (REMINISCENCE): focus on patients with brain metastases
Debus, D. (Author), Rohrer, P. M. (Author), Grote, C. (Author), Kähler, K. (Author), Koch, L. (Author), Reichenbach, F. (Author), Terheyden, P. (Author) & Nguyen, V. (Author)
2023Activity: Talk, presentation or poster › Poster
-
REMINISCENCE: Fokus auf Patienten mit Hirnmetastasen
Rohrer, P. M. (Speaker), Debus, D. (Author), Grote, C. (Author), Kähler, K. (Author), Koch, L. (Author), Reichenbach, F. (Author), Terheyden, P. (Author) & Nguyen, V. (Author)
2023Activity: Talk, presentation or poster › Poster
-
Retrospective Single Case Reports on the Treatment of Advanced BRAFV600-mutated Malignant Melanoma with Encorafenib plus Binimetinib (REMINISCENCE)
Debus, D. (Author), Alter, M. (Author), Dernoscheg, M.-T. (Author), Rohrer, P. M. (Author), Koch, L. (Author), Nguyen, V. (Author) & Terheyden, P. (Author)
2022Activity: Talk, presentation or poster › Poster
-
Retrospective Survey of Individual Case Reports on Treatment Situations in Patients with locally advanced or metastatic, BRAFV600-mutated Melanoma with Encorafenib and Binimetinib (REMINISCENCE).
Grote, C. (Author), Debus, D. (Author), Bluhm, L. (Author), Koch, L. (Author), Alter, M. (Author), Dernoscheg, M.-T. (Author), Nepel, C. R. (Author), Rohrer, P. M. (Author), Kahler, K. (Author), Tuting, T. (Author), Gengen-Bacher, L. (Author), Nguyen, V. (Author) & Terheyden, P. (Author)
2022Activity: Talk, presentation or poster › Poster
-
Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
Berger, M. (Author), Thueringer, A. (Author), Franz, D. (Author), Dandachi, N. (Author), Talakic, E. (Author), Richtig, G. (Author), Richtig, E. (Author), Rohrer, P. M. (Author), Koch, L. (Author), Wolf, I. H. (Author), Koch, C. (Author), Rainer, B. (Author), Koeller, M. (Author), Pichler, M. (Author), Kashofer, K. (Author) & Aigelsreiter, A. (Author)
2020Activity: Talk, presentation or poster › Scientific talk or presentation › Online